全球现有100多个艾滋病疫苗进入Ⅰ期临床研究,仅3个最后进入Ⅲ期临床;目前只剩下1个还在实验中,疫苗研究前景似乎并不光明。来自于美国马里兰大学人类病毒研究所的所长、医学院微生物学和免疫学系教授罗伯特?盖洛博士对此强调指出,疫苗研究面临三大困难,能否成功需四年后才能确定。盖洛博士在“2005预防和控制HIV感染新方法国际研讨会”上报道说,在全球范围内,一些侯选疫苗正在进行研究,包括中国研发的;但能否成功,目前还 There are more than 100 AIDS vaccines in the world entering Phase I clinical trials, only 3 of them finally entering Phase III clinical trials. Currently, only one is still in the experiment. The vaccine research prospects do not seem bright. Dr. Robert Gallo, director of the Institute of Human Virology at the University of Maryland, and professor of microbiology and immunology at the University of Maryland, emphasized that vaccine research faces three major challenges that can not be determined until four years after its success. Dr. Gallo has reported in the “2005 International Symposium on New Methods of HIV Prevention and Control” that a number of candidate vaccines are being researched globally, including those developed in China; however, the success of this vaccine is still